Homepage2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Vorige slotkoers
$Â 13,10
Dag-range
$Â 13,07 - $Â 13,65
Jaar-range
$Â 6,20 - $Â 15,08
Beurswaarde
35,33Â mld. HKD
Gem. volume
9,11Â mln.
Koers/winst
34,54
Dividendrendement
1,28%
Primaire beurs
HKG
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,79Â mld. | 15,14% |
Bedrijfskosten | 1,09Â mld. | 15,97% |
Netto inkomsten | 301,80Â mln. | 32,20% |
Netto winstmarge | 16,84 | 14,87% |
Winst per aandeel | — | — |
EBITDA | 409,84Â mln. | 18,60% |
Effectief belastingtarief | 8,89% | — |
Balans
Totale activa
Totale passiva
| (CNY) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,68Â mld. | -12,44% |
Totale activa | 12,60Â mld. | 7,61% |
Totale passiva | 5,37Â mld. | 11,79% |
Totaal aandelenvermogen | 7,23 mld. | — |
Uitstaande aandelen | 2,47 mld. | — |
Koers-boekwaardeverhouding | 4,49 | — |
Rendement op activa | 7,08% | — |
Rendement op kapitaal | 10,55% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 301,80Â mln. | 32,20% |
Operationele kasstroom | 433,27Â mln. | 0,45% |
Kasstroom uit beleggingen | -55,17Â mln. | 72,55% |
Kasstroom uit financiering | -13,48Â mln. | -109,41% |
Nettomutatie in liquide middelen | 363,72Â mln. | -2,72% |
Vrije kasstroom | 289,11Â mln. | 33,93% |
Over
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
CEO
Opgericht
1995
Hoofdvestiging
Website
Werknemers
6.815
